Regulatory Submissions

Pre-market submissions define your timeline to market. EMMA International’s regulatory experts prepare comprehensive pharmaceutical, biologics, and medical device submissions. Whether combined with regulatory strategy or used as a standalone service, with EMMA International, you’re assured accurate, timely submissions that streamline your path to approval or clearance.

Pharmaceuticals

Pre-Investigational New Drug Application (Pre-IND)

Don’t forget the most important step on your path to market. EMMA International helps you navigate FDA requirements and prepare your pre-IND package, thus ensuring you gain valuable feedback from the FDA.

Investigational New Drug Application (IND)

EMMA International takes care of the heavy lifting to prepare a comprehensive IND package so you can start your clinical investigation.

Abbreviated New Drug Application/New Drug Application (ANDA/NDA)

Our regulatory experts compile your abbreviated new drug application or new drug application to ensure your drug product reaches all the commercialization milestones on your timeline.

Biologics

Pre- Investigational New Drug /Pre- Investigational Device Exemption

Don’t forget the most important step on your path to market. EMMA International helps you navigate FDA requirements and prepare your pre-IND package, thus ensuring you gain valuable feedback from the FDA.

Investigational New Drug (IND) or Investigational Device Exemption (IDE)

EMMA International prepares your investigational submission package to assure your readiness for clinical investigation.

Biologics License Application (BLA)

Our regulatory experts work alongside your stakeholders to compile your BLA. Our track record of successful approvals speaks for itself.

Medical Devices/Digital Health

Pre- Investigational Device Exemption

Don’t forget the most important step on your path to market. EMMA International helps you navigate FDA requirements and prepare your pre-IDE package, as applicable, thus ensuring you gain valuable feedback from the FDA.

Investigational Device Exemption (IDE)

EMMA International can prepare your investigational submission package to ensure your readiness for clinical investigation.

Q-Submissions

Getting innovative products to market can be a daunting task. With EMMA International on your side, a Q-Sub becomes an even more valuable mechanism to obtain some feedback from the FDA. We compile the documentation, facilitate pre-submissions and meetings with the FDA, and address all concerns raised by the agency on your behalf.

510(k)/ Premarket Approval (PMA)/ DeNovo/Humanitarian Device Exemption (HDE)

From former FDA officials to former regulatory affairs executives, our regulatory experts guarantee the outcome of your regulatory submissions regardless of complexity.

Ready to get expert assistance with your regulatory submissions? Speak with one of our experts today.

Ready to learn more about working with us?

Regulatory Submission Resources

COVID-19 Fraudulent Products

COVID-19 Fraudulent Products

It has been a wild past two years trying to figure out what products can mitigate, treat, diagnose or even cure ...
Microbiological Testing

Microbiological Testing

Many microbes are harmless to humans, but some can cause serious health problems. Microbes can spoil food, ...
Reporting Adverse Events

Reporting Adverse Events

Post-market surveillance is necessary for ensuring compliance as regulatory bodies have the authority to impose ...

Pin It on Pinterest